fashion -WSS

fashion

author：knowledge 2025-09-29 22:49:58 - browse：44922

WASHINGTON — A White House task force created to work on drug shortage reforms has yet to contact the lawmakers who are writing legislation to stem shortages — and it’s not clear when the task force will recommend policies.

The White House formed a task force at the beginning of 2023 to deal with the issue of persistent drug shortages. Fifty-seven percent of hospital pharmacists said they are facing critical shortages of chemotherapy drugs in a new survey from the American Society of Health-System Pharmacists. Hospital pharmacists also reported significant shortages of steroids, hormonal drugs, and oral liquids such as amoxicillin and lidocaine.

Yet industry and patient representatives who have met with task force members said there has been no indication of when they will make recommendations that could spur federal agencies to act and steer the debate in Congress.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Fauci’s Covid grilling leads GOP to weigh foreign research rules

entertainment

leisure time

WSS

What is artificial intelligence? Experts weigh in

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

JPM 2024: Verve Therapeutics looks to mainstream genome editing

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

As JPM 2024 winds down, some health tech firms project optimism

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

focus

fashion

leisure time

Trump demands the U.S. pay no more for drugs than other countries … again

Why the advice to take all your antibiotics may be wrong

Bright Health sells Medicare Advantage business to Molina

Caregivers of transplant patients call for more support, training

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

United colonoscopy coverage change 'may cost lives,' doctors say

Designating disabled people as health disparity population is crucial

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

JPM 2024: Verve Therapeutics looks to mainstream genome editing

focus

Biden White House, tech companies launch new safeguards around emerging AI technology

As JPM 2024 winds down, some health tech firms project optimism

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

GSK to buy asthma

New chart reveals military’s vast involvement in Operation Warp Speed

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

entertainment

hotspot

leisure time

Wikipedia